APA (7th ed.) Citation

Lee, J., Ahn, H. K., Lee, K., Jung, K. H., Park, Y. H., Sim, S. H., . . . Committee, K. C. S. G. B. C. Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21). BMC.

Chicago Style (17th ed.) Citation

Lee, Jieun, et al. Randomized, Phase II Trial to Evaluate the Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy Compared to Capecitabine Monotherapy for Triple Receptor-negative Breast Cancer with Residual Invasive Cancer After Neoadjuvant Chemotherapy (MIRINAE Trial, KCSG-BR18-21). BMC.

MLA (9th ed.) Citation

Lee, Jieun, et al. Randomized, Phase II Trial to Evaluate the Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy Compared to Capecitabine Monotherapy for Triple Receptor-negative Breast Cancer with Residual Invasive Cancer After Neoadjuvant Chemotherapy (MIRINAE Trial, KCSG-BR18-21). BMC.